Toggle Main Menu Toggle Search

Open Access padlockePrints

Can Routine Anti-Inflammatory Medications Reduce Population Dementia Risk?

Lookup NU author(s): Dr Connor Richardson, Professor Adam ToddORCiD, Professor Fiona MatthewsORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

BackgroundEvidence from epidemiological and clinical studies of the effect of anti-inflammatory medication on dementia risk has been mixed. Over the past two decades there has been recurring epidemiological evidence that the use of NSAID’s for chronic inflammatory conditions is associated with a lower incidence of dementia.MethodCognitive Function and Ageing Study (CFAS) undertook baseline interviews in populations aged 65+ years in England and Wales (1989-1994). Three areas (CFAS I) were selected for new sampling two decades later (2008-2011) with same geographical boundaries, sampling and approach methods (CFAS II). At 2 years CFAS I interviewed 5,156 (76% response) with 5,288 interviewed in CFAS II (74% response). Data on medication use and dementia status was assessed at each wave.ResultLow dose aspirin (< 150 mg) use was associated by a reduction in dementia incidence rate (IR) in women from 60.99 (95% CI: 47.6, 78.2) per 1000 person-years to 44.1 (95% CI: 2.0, 45.4) in 1993 and from 44.5 (33.7, 58.7) to 38.6 (27.2, 54.9) in 2013. No reduction in men was found.ConclusionThis study shows evidence that routine use of low-dose aspirin reduces population risk of dementia in women. Mixed results in men show further analysis is needed to asses the effect over a longer follow-up with a broader range of anti-inflammatory medication.


Publication metadata

Author(s): Richardson CD, Todd A, Matthews FE

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Alzheimer’s Association International Conference AAIC 2024

Year of Conference: 2024

Pages: e092406

Print publication date: 01/12/2024

Online publication date: 09/01/2025

Acceptance date: 02/04/2024

Date deposited: 22/05/2025

ISSN: 1552-5260

Publisher: John Wiley & Sons, Inc.

URL: https://doi.org/10.1002/alz.092406

DOI: 10.1002/alz.092406

PubMed id: 11715312

Series Title: Alzheimer’s & Dementia


Share